These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integrating machine learning and single-cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers. Zhang P; Feng J; Rui M; Xie J; Zhang L; Zhang Z J Cell Mol Med; 2024 Jul; 28(13):e18516. PubMed ID: 38958577 [TBL] [Abstract][Full Text] [Related]
3. Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules. Zhou D; Li YQ; Liu QX; Deng XF; Chen L; Li MY; Zhang J; Lu X; Zheng H; Dai JG Cancer Med; 2024 Jun; 13(11):e7383. PubMed ID: 38864483 [TBL] [Abstract][Full Text] [Related]
4. Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. Ye B; Hongting G; Zhuang W; Chen C; Yi S; Tang X; Jiang A; Zhong Y J Cell Mol Med; 2024 Jul; 28(14):e18564. PubMed ID: 39046884 [TBL] [Abstract][Full Text] [Related]
5. Advancing lung adenocarcinoma prognosis and immunotherapy prediction with a multi-omics consensus machine learning approach. Lin H; Zhang X; Feng Y; Gong Z; Li J; Wang W; Fan J J Cell Mol Med; 2024 Jul; 28(13):e18520. PubMed ID: 38958523 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
7. Deciphering Dormant Cells of Lung Adenocarcinoma: Prognostic Insights from O-glycosylation-Related Tumor Dormancy Genes Using Machine Learning. Dong C; Liu Y; Chong S; Zeng J; Bian Z; Chen X; Fan S Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273449 [TBL] [Abstract][Full Text] [Related]
8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
10. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments. Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z Cells; 2021 Dec; 11(1):. PubMed ID: 35011587 [TBL] [Abstract][Full Text] [Related]
11. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
12. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Zhu J; Fan Y; Xiong Y; Wang W; Chen J; Xia Y; Lei J; Gong L; Sun S; Jiang T Exp Mol Med; 2022 Nov; 54(11):2060-2076. PubMed ID: 36434043 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038 [TBL] [Abstract][Full Text] [Related]
14. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related]
15. High Expression of Deng H; Huang Y; Wang L; Chen M Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373 [TBL] [Abstract][Full Text] [Related]
16. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma. Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
18. Prognostic and immunotherapeutic implications of bilirubin metabolism-associated genes in lung adenocarcinoma. Ren K; Ling X; Chen L; Li Z; Huang T J Cell Mol Med; 2024 May; 28(9):e18346. PubMed ID: 38693853 [TBL] [Abstract][Full Text] [Related]
19. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma. Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267 [TBL] [Abstract][Full Text] [Related]
20. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD. Ma C; Gu Z; Yang Y J Cell Mol Med; 2024 Apr; 28(8):e18282. PubMed ID: 38647237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]